Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 383)
Posted On: 10/07/2025 7:00:01 AM
Post# of 157781
Posted By: biloxiblues
From Redit

Overview of breakthrough designation
To qualify for FDA Breakthrough Designation, applicants must submit early clinical evidence showing their drug or device offers a substantial improvement over existing therapies for a serious or life-threatening condition, with preliminary data demonstrating a significant benefit. For Drugs & Biologics Serious or Life-Threatening Condition: The drug must be intended to treat a serious or life-threatening disease or condition.
Preliminary Clinical Evidence: Early clinical evidence must demonstrate the drug may offer a substantial improvement over available therapy on at least one clinically significant endpoint. This could include improved survival, reduced disease progression, or superior symptom management. Unmet Medical Need: The drug must address a condition with limited or ineffective existing treatments, representing an unmet medical need. $sprb launched 1400% today on btd. That would put us at $14/share. Also look at the price history on it. $4 back in March 2025 but in 2020 it was $2k/share.


https://finance.yahoo.com/quote/SPRB/













(2)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site